Healthcare - Biotechnology - NASDAQ - US
$ 31.44
-4.35 %
$ 2.98 B
Market Cap
-20.96
P/E
BALANCE SHEET
340 M
ASSETS
21.2 M
LIABILITIES
319 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Edgewise Therapeutics, Inc.
| Current Assets | 327 M |
| Cash & Short-Term Investments | 318 M |
| Receivables | 0 |
| Other Current Assets | 8.6 M |
| Non-Current Assets | 13 M |
| Long-Term Investments | 0 |
| PP&E | 12.7 M |
| Other Non-Current Assets | 348 K |
| Current Liabilities | 16.8 M |
| Accounts Payable | 4.02 M |
| Short-Term Debt | 1.96 M |
| Other Current Liabilities | 10.8 M |
| Non-Current Liabilities | 4.43 M |
| Long-Term Debt | 4.43 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 86.1 | 351.9 | 280.8 | 104.9 | 23.7 |
| Short Term Investments | 232.3 | 330.0 | 265.2 | 24.2 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.6 | 10.1 | 6.0 | 0.6 | 0.4 |
| Total Current Assets | 327.0 | 351.9 | 280.8 | 129.6 | 24.0 |
| PP&E | 12.7 | 9.9 | 0.9 | 0.5 | 0.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.3 | 5.3 | 3.5 | 1.0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 340.0 | 367.1 | 285.2 | 131.1 | 24.5 |
| LIABILITIES | |||||
| Accounts Payable | 4.0 | 6.1 | 3.8 | 1.6 | 0.7 |
| Short Term Debt | 2.0 | 1.2 | 0 | 0 | 0 |
| Other Current Liabilities | 10.8 | 9.3 | 6.7 | 2.8 | 0.5 |
| Total Current Liabilities | 16.8 | 16.6 | 10.5 | 4.3 | 1.1 |
| Long Term Debt | 4.4 | 3.8 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0.3 | 0 | 0 |
| Total Liabilities | 21.2 | 20.4 | 10.8 | 164.6 | 41.4 |
| EQUITY | |||||
| Common Stock | 7 K | 6 K | 5 K | 0 | 0 |
| Retained Earnings | (244.8) | (144.6) | (77.0) | (34.1) | (17.0) |
| Other Accumulative Comprehensive Income/Loss | 99 K | (1.4) | (0.5) | 0 | 0 |
| Total Equity | 318.8 | 346.7 | 274.4 | (33.4) | (16.9) |
| Total Liabilities and Equity | 340.0 | 367.1 | 285.2 | 131.1 | 24.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 63.7 | 53.6 | 49.5 | 49.2 | 49.2 |